INTS
INTENSITY THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$3.50
+3.55%Oct 30, 2026, 12:00 UTC
Intensity Therapeutics announced that it will report third-quarter 2026 financial results before the market opens on November 5, 2026, and hold a conference call at 8:00 a.m. ET to review the results and provide a corporate update.
Source:Aug 11, 2026, 17:47 UTC
Intensity Therapeutics, Inc. held its Q2 2026 earnings call on August 11, 2026.
Source: